Catalyst Wire Dossier Catalyst Wire Dossier

Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia

· Beijing Anzhen Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia, covering 2024-10-02 to 2024-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia [NA]

See pricing